Mount Sinai offers a broad range of surgical, radiation and chemotherapies to treat cancers at every stage. In addition to standard treatments, innovative therapies include:

  • Minimally invasive lung cancer surgery: Mount Sinai faculty who have led national trials in VATS lobectomy are the leaders in minimally invasive surgical approaches in the New York tri-state area. This technique may be the procedure of choice, particularly for patients with small tumor nodules of the lung.
  • Photodynamic therapy (PDT): This treatment is designed for patients with unresectable tumors of the airway and esophagus, particularly those patients who experience difficulty breathing or swallowing. PDT – which involves a light-activated drug in combination with a medical laser – is often the palliative treatment of choice
  • Laser therapy and stenting for esophageal and lung cancer: As alternative palliative treatments, laser therapy and stenting can have positive results on a patient’s quality of life. Laser therapy may be used to burn away portions of an unresectable tumor of a blocked esophagus or airway. Stenting may be the option of choice following laser therapy, making the effects more durable or, used as a technique to open the airway or esophagus when laser therapy is not a therapeutic option.
  • Radiofrequency ablation: This technology permits patients who are not surgical candidates to undergo tumor removal.
  • Stereotactic radiosurgery: The Novalis® Shaped Beam Surgery System is the newest treatment in lung cancer armamentarium. The device delivers precise, focused radiation to tumors, minimizing damage to surrounding tissue.
  • Brachytherapy: This treatment delivers radiation therapy via implantable seeds and impregnated mesh, an effective therapeutic alternative for patients with breathing compromise.
  • Small catheter approach: This technique is useful in the treatment of malignant pleural effusions and usually does not require a hospital stay.
  • New approaches for the treatment of patients with mesothelioma

Access to Mount Sinai-led clinical trials, including those designed to stage cancer and employ cutting-edge biologic therapies.

Clinical care at Mount Sinai may also draw upon behavioral medicine, genetic testing, and environmental medicine. In addition, Mount Sinai’s aggressive, multimodal approach to advanced tumors gives new hope to patients whom others have diagnosed as incurable.